Stocks and Investing Stocks and Investing
Sat, November 30, 2024
[ 06:31 AM ] - United States, Thomas Matters
3 ISA strategies to consider
Fri, November 29, 2024
[ 02:30 PM ] - United States, Thomas Matters
Stocks Resume Post-Election Rise

Here's Why Qiagen (QGEN) is a Strong Value Stock


Published on 2024-11-29 12:30:55 - Thomas Matters, WOPRAI
  Print publication without navigation

  • Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank,

The article from MSN Money discusses why Qiagen (QGEN) is considered a strong value stock. Qiagen, a company specializing in molecular diagnostics and sample preparation technologies, has shown robust financial health with a forward P/E ratio of 19.87, which is lower than the industry average, suggesting it might be undervalued. The company's Value Score is a B, indicating good value based on several valuation metrics. Additionally, Qiagen has a Zacks Rank of #2 (Buy), which reflects positive earnings estimate revisions. The article highlights Qiagen's consistent performance, with a history of surpassing earnings expectations, and its strategic positioning in the growing market for diagnostic solutions, particularly in areas like infectious diseases, oncology, and genetic testing. This combination of factors makes Qiagen an attractive option for investors looking for value stocks with growth potential.

Read the Full MSN Article at [ https://www.msn.com/en-us/money/topstocks/here-s-why-qiagen-qgen-is-a-strong-value-stock/ar-AA1uZyib ]

Contributing Sources